Search results for " biopharmaceuticals"
Article
Fifteen Years of Progress: Biopharmaceutical Industry Survey Results
In a BioPlan survey of 100 participants at the BIO conference 10 years ago, China was noted nearly universally as an unacceptable potential partner in biopharmaceuticals due to the lack of intellectua…
Article
Risk Assessment and Mitigation in Biopharmaceutical Manufacturing
Risk Mitigation Strategies
BioPharm: What strategy does your company use to mitigate risk in the manufacture of biopharmaceuticals?
AstraZeneca: To obtain the most valuable risk mitigation pla…
Article
Leveraging Data for Better Biopharmaceutical Process Control
Leveraging Data for Better Biopharmaceutical Process Control
The need to improve and understand processes is moving PAT and more advanced control strategies beyond the lab into manufacturing and dow…
Article
Adherent Cell Culture in Biopharmaceutical Applications: The Cell-Detachment Challenge
The successful development of biopharmaceuticals produced from animal cell culture and other applications of adherent cells in the biopharmaceutical industry has spurred research on alternative cell-d…
Article
Bioburden Control in the Biopharmaceutical Industry
Protecting against microbiological contamination over the whole manufacturing process grows increasingly important.
By Mostafa Eissa
The biopharmaceutical industry has witn…
Article
Cost Considerations Drive Lean Technology in Biopharmaceutical Manufacturing
Monoclonal antibodies (mAbs) are the most common and most well-known class of biopharmaceuticals. As of February 2017, FDA lists 68 approved mAbs, and approvals have been increasing each year since th…
Article
Outsourcing Trends in Biopharmaceutical Manufacturing
Markets for biopharmaceuticals are growing in many developing countries, such as India and China, with increased incomes, a new middle class and improved healthcare. Indeed, China (8.6%) and India (8.…
Article
State of the Biopharmaceutical Industry: Lessons from 2018 Survey Data
I also continue to be surprised by the magnitude of efforts in follow-on biopharmaceuticals, particularly biosimilars. BioPlan's Biosimilar/Biobetters Pipeline Directory is now tracking over 1,000 bio…
Article
A Look into the Future of Biopharmaceutical Quality
To gain perspective on what the future holds for biopharmaceuticals and how the industry and regulators will address quality going forward, BioPharm International spoke with Anthony Newcombe, principa…
Article
The New World of Biopharmaceutical Manufacturing
Fill and finish technology still has room to grow, including the delivery systems of biopharmaceuticals.
Isberg (Entegris): I continue to hear that one of the biggest challenges is consis…